Background: In a recent randomized intervention trial, the risk of prostate cancer for men
receiving a daily supplement of 200 µg selenium was one third of that for men receiving …

Results of a randomized controlled trial have suggested a protective effect of selenium
against prostate cancer. Few other prospective studies have been conducted to confirm or …

Background: Epidemiologic studies suggest that low selenium levels are associated with an
increased incidence of prostate cancer, although results are conflicting. We examined the …

OBJECTIVE To present the results (to January 1996, the end of blinded treatment) of the
Nutritional Prevention of Cancer (NPC) Trial, a randomized trial of selenium (200 µg daily) …

It is suspected that selenium is protective against prostate cancer. To test this hypothesis, we
conducted a nested case-control study in a cohort of 9345 Japanese-American men …

PURPOSE: Epidemiological studies and a randomized intervention trial suggest that the risk
of prostate cancer may be reduced by selenium intake. We investigated whether plasma …

Objective To test if supplemental dietary selenium is associated with changes in the
incidence of prostate cancer. Patients and method A total of 974 men with a history of either …

Background: Some evidence indicates that a low selenium intake may be associated with an
increased risk of prostate cancer. Objective: The aim of this study was to investigate the …

To study the possible role of dietary and supplementary selenium intake in the etiology of
cancer, we carried out a case-control study of breast, colon, and prostate cancer in Montreal …

Background: Selenium is a potential chemopreventive agent against prostate cancer, whose
chemoprotective effects are possibly mediated through the antioxidative properties of …